Baricitinib could improve the prognosis of anti-MDA5 antibody positive dermatomyositis associated interstitial lung disease.

Saved in:
Bibliographic Details
Title: Baricitinib could improve the prognosis of anti-MDA5 antibody positive dermatomyositis associated interstitial lung disease.
Authors: Zhu S; Department of Rheumatology, Henan Provincial People's Hospital, Zhengzhou City, Henan Province, China., Li S; Department of Rheumatology, The Key Laboratory of Myositis, China-Japan Friendship Hospital, Yinghua East Road, Chaoyang District, Beijing, 100029, China., Shi L; Department of Rheumatology, Henan Provincial People's Hospital, Zhengzhou City, Henan Province, China., Chu T; Department of Rheumatology, Henan Provincial People's Hospital, Zhengzhou City, Henan Province, China., Huang Z; Department of Radiology, China-Japan Friendship Hospital, Beijing, China., Lu X; Department of Rheumatology, The Key Laboratory of Myositis, China-Japan Friendship Hospital, Yinghua East Road, Chaoyang District, Beijing, 100029, China., Wang G; Department of Rheumatology, The Key Laboratory of Myositis, China-Japan Friendship Hospital, Yinghua East Road, Chaoyang District, Beijing, 100029, China., Ge Y; Department of Rheumatology, The Key Laboratory of Myositis, China-Japan Friendship Hospital, Yinghua East Road, Chaoyang District, Beijing, 100029, China. gyp2016@163.com.
Source: Arthritis research & therapy [Arthritis Res Ther] 2025 Nov 14; Vol. 27 (1), pp. 214. Date of Electronic Publication: 2025 Nov 14.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362 (Electronic) Linking ISSN: 14786354 NLM ISO Abbreviation: Arthritis Res Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1478-6362
DOI:10.1186/s13075-025-03675-9